BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27073044)

  • 1. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
    Rajabi O; Layegh P; Hashemzadeh S; Khoddami M
    Dermatol Ther; 2016 Sep; 29(5):358-363. PubMed ID: 27073044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Krolewiecki AJ; Romero HD; Cajal SP; Abraham D; Mimori T; Matsumoto T; Juarez M; Taranto NJ
    Am J Trop Med Hyg; 2007 Oct; 77(4):640-6. PubMed ID: 17978064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
    Mohammadzadeh M; Behnaz F; Golshan Z
    J Infect Public Health; 2013 Apr; 6(2):120-4. PubMed ID: 23537825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R; Handjani F; Nouhpisheh MK
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride (Thio-Ben) along with cryotherapy: a single-blind randomized clinical trial.
    Daie Parizi MH; Karvar M; Sharifi I; Bahrampour A; Heshmat Khah A; Rahnama Z; Baziar Z; Amiri R
    Dermatol Ther; 2015; 28(3):140-6. PubMed ID: 25847678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
    BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of efficacy of liposomal glucantime in the treatment of cutaneous leishmaniasis.
    Ghoyonlo VM; Jafari MR; Yazdanpanah MJ; Esmaili H; Noori S; Kiafar B
    Indian J Dermatol Venereol Leprol; 2016; 82(3):347-9. PubMed ID: 27088953
    [No Abstract]   [Full Text] [Related]  

  • 9. Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
    Dastgheib L; Naseri M; Mirashe Z
    Int J Dermatol; 2012 Dec; 51(12):1508-11. PubMed ID: 23171020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
    Solomon M; Ollech A; Pavlotsky F; Barzilai A; Schwartz E; Baum S; Astman N
    Acta Derm Venereol; 2024 Apr; 104():adv35089. PubMed ID: 38682801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
    Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
    Faghihi G; Tavakoli-kia R
    Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lesion improvement in lupoid leishmaniasis patients with two treatment approaches: trichloroacetic Acid and intralesional meglumine antimoniate.
    Banihashemi M; Yazdanpanah MJ; Amirsolymani H; Yousefzadeh H
    J Cutan Med Surg; 2015; 19(1):35-9. PubMed ID: 25775661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil.
    Toledo Junior A; Daher AB; Amaral TA; Carvalho SF; Romero GA; Rabello A
    Rev Soc Bras Med Trop; 2014; 47(6):756-62. PubMed ID: 25626655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
    Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
    Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
    Uzun S; Durdu M; Culha G; Allahverdiyev AM; Memisoglu HR
    J Parasitol; 2004 Aug; 90(4):853-9. PubMed ID: 15357081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis.
    Mujtaba G; Khalid M
    Int J Dermatol; 1999 Aug; 38(8):607-9. PubMed ID: 10487452
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
    Shamsi Meymandi S; Zandi S; Aghaie H; Heshmatkhah A
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):587-91. PubMed ID: 20666876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.